Prolyl hydroxylase inhibitors, roxadustat and daprodustat, inhibit platelet activation and thrombosis through the PI3K/AKT/HIF-1α pathway

Biochemical Pharmacology 2026

View at publisher

Authors: Yujing Yuan, Zhanzhan Yang, Fang Guo, Tao Liu, Qin Li, Kui Wen, Gang Liu, Yajun Zhou, Yajun Zhou

DOI: 10.1016/j.bcp.2026.117808

Cited by: 0

References: 52

Fields of Study & Subjects

Platelet Disorders and Treatments Erythropoietin and Anemia Treatment Blood Coagulation and Thrombosis Mechanisms

References 52